Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Dr. Reddy's Laboratories Ltd ADR (RDY)

Dr. Reddy's Laboratories Ltd ADR (RDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dr. Reddy's Laboratories Ltd ADR 8-2-337 ROAD NO.3 BANJARA HILLS HYDERABAD K7 500-034 IND

www.drreddys.com Employees: 27,048 P: 91-40-4900-2900 F: 404-900-2999

Sector:

Medical

Description:

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.

Key Statistics

Overview:

Market Capitalization, $K 12,070,802
Enterprise Value, $K 12,449,722
Shares Outstanding, K 834,772
Annual Sales, $ 3,841 M
Annual Net Income, $ 667,220 K
Last Quarter Sales, $ 996,000 K
Last Quarter Net Income, $ 187,000 K
EBIT, $ 847,750 K
EBITDA, $ 1,049 M
60-Month Beta 0.33
% of Insider Shareholders 2.00%
% of Institutional Shareholders 3.85%
Float, K 818,077
% Float 98.00%
Short Volume Ratio 0.28

Growth:

1-Year Return 5.52%
3-Year Return 28.40%
5-Year Return 35.29%
5-Year Revenue Growth 65.86%
5-Year Earnings Growth 41.07%
5-Year Dividend Growth 60.00%

Per-Share Information:

Most Recent Earnings 0.22 on 05/09/25
Next Earnings Date 05/13/25
Earnings Per Share ttm 0.66
EPS Growth vs. Prev Qtr 10.00%
EPS Growth vs. Prev Year 17.02%
Annual Dividend Rate, $ 0.08
Annual Dividend Yield 0.56%
Most Recent Dividend 0.404 on 07/30/24
Next Ex-Dividends Date 07/30/24
Dividend Payable Date 08/12/24
Dividend Payout Ratio 10.05%
Most Recent Split 5-1 on 11/05/24

RDY Ratios

Ratio
Price/Earnings ttm 21.88
Price/Earnings forward 18.16
Price/Earnings to Growth 5.90
Return-on-Equity % 17.94%
Return-on-Assets % 12.21%
Profit Margin % 17.37%
Debt/Equity 0.14
Price/Sales 3.16
Price/Cash Flow 13.96
Price/Book 3.03
Book Value/Share 4.77
Interest Coverage 28.14

RDY Dividends

Date Value
07/30/24 $0.4040
07/28/23 $0.4100
07/07/23 $0.4140
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar